 | • レポートコード：D0GIR-09263 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、静脈内注射免疫グロブリンの世界市場を広く調査・分析し、今後の市場展望をまとめております。静脈内注射免疫グロブリンの種類別市場規模（1g/20ml、1.25g/25ml、2.5g/50ml、5g/100ml、10g/200ml）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Boya-Bio、CTBB、Guangdong Shuagnlin Bio-pharmacy、Beijing Tiantan Biological Products、Shanghai RAAS、Hualan Bio、Sinopharm、Weiguang Biological、Nanyue Biopharming ・地域別グローバル市場分析 2015年-2020年 ・静脈内注射免疫グロブリンの北米市場（アメリカ、カナダ、メキシコ） ・静脈内注射免疫グロブリンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・静脈内注射免疫グロブリンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・静脈内注射免疫グロブリンの南米市場（ブラジル、アルゼンチン） ・静脈内注射免疫グロブリンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：1g/20ml、1.25g/25ml、2.5g/50ml、5g/100ml、10g/200ml ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Intravenous Injection Immunoglobulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Intravenous Injection Immunoglobulin sales will be xx in 2020 from Intravenous Injection Immunoglobulin million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Intravenous Injection Immunoglobulin market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Intravenous Injection Immunoglobulin industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Intravenous Injection Immunoglobulin and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Intravenous Injection Immunoglobulin market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Intravenous Injection Immunoglobulin market has been segmented into
1g/20ml
1.25g/25ml
2.5g/50ml
5g/100ml
10g/200ml
By Application, Intravenous Injection Immunoglobulin has been segmented into:
Hospital
Clinic
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Intravenous Injection Immunoglobulin market presented in the report. This section sheds light on the sales growth of different regional and country-level Intravenous Injection Immunoglobulin markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Intravenous Injection Immunoglobulin market.
The report offers in-depth assessment of the growth and other aspects of the Intravenous Injection Immunoglobulin market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Intravenous Injection Immunoglobulin Market Share Analysis
Intravenous Injection Immunoglobulin competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Intravenous Injection Immunoglobulin sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Intravenous Injection Immunoglobulin sales, revenue and market share for each player covered in this report.
The major players covered in Intravenous Injection Immunoglobulin are:
Boya-Bio
CTBB
Guangdong Shuagnlin Bio-pharmacy
Beijing Tiantan Biological Products
Shanghai RAAS
Hualan Bio
Sinopharm
Weiguang Biological
Nanyue Biopharming
Among other players domestic and global, Intravenous Injection Immunoglobulin market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intravenous Injection Immunoglobulin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Intravenous Injection Immunoglobulin, with price, sales, revenue and global market share of Intravenous Injection Immunoglobulin in 2018 and 2019.
Chapter 3, the Intravenous Injection Immunoglobulin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravenous Injection Immunoglobulin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Intravenous Injection Immunoglobulin market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Intravenous Injection Immunoglobulin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Intravenous Injection Immunoglobulin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Intravenous Injection Immunoglobulin Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 1g/20ml
1.2.3 1.25g/25ml
1.2.4 2.5g/50ml
1.2.5 5g/100ml
1.2.6 10g/200ml
1.3 Market Analysis by Application
1.3.1 Overview: Global Intravenous Injection Immunoglobulin Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Overview of Global Intravenous Injection Immunoglobulin Market
1.4.1 Global Intravenous Injection Immunoglobulin Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Intravenous Injection Immunoglobulin Industry Impact
1.6.1 COVID-19 Potential Implications for the Intravenous Injection Immunoglobulin
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Intravenous Injection Immunoglobulin
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Boya-Bio
2.1.1 Boya-Bio Details
2.1.2 Boya-Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Boya-Bio SWOT Analysis
2.1.4 Boya-Bio Product and Services
2.1.5 Boya-Bio Intravenous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 CTBB
2.2.1 CTBB Details
2.2.2 CTBB Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 CTBB SWOT Analysis
2.2.4 CTBB Product and Services
2.2.5 CTBB Intravenous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Guangdong Shuagnlin Bio-pharmacy
2.3.1 Guangdong Shuagnlin Bio-pharmacy Details
2.3.2 Guangdong Shuagnlin Bio-pharmacy Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Guangdong Shuagnlin Bio-pharmacy SWOT Analysis
2.3.4 Guangdong Shuagnlin Bio-pharmacy Product and Services
2.3.5 Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Beijing Tiantan Biological Products
2.4.1 Beijing Tiantan Biological Products Details
2.4.2 Beijing Tiantan Biological Products Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Beijing Tiantan Biological Products SWOT Analysis
2.4.4 Beijing Tiantan Biological Products Product and Services
2.4.5 Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Shanghai RAAS
2.5.1 Shanghai RAAS Details
2.5.2 Shanghai RAAS Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Shanghai RAAS SWOT Analysis
2.5.4 Shanghai RAAS Product and Services
2.5.5 Shanghai RAAS Intravenous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Hualan Bio
2.6.1 Hualan Bio Details
2.6.2 Hualan Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Hualan Bio Product and Services
2.6.4 Hualan Bio Intravenous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sinopharm
2.7.1 Sinopharm Details
2.7.2 Sinopharm Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sinopharm Product and Services
2.7.4 Sinopharm Intravenous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Weiguang Biological
2.8.1 Weiguang Biological Details
2.8.2 Weiguang Biological Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Weiguang Biological Product and Services
2.8.4 Weiguang Biological Intravenous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Nanyue Biopharming
2.9.1 Nanyue Biopharming Details
2.9.2 Nanyue Biopharming Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Nanyue Biopharming Product and Services
2.9.4 Nanyue Biopharming Intravenous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Intravenous Injection Immunoglobulin Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Intravenous Injection Immunoglobulin Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Intravenous Injection Immunoglobulin Manufacturer Market Share in 2019
3.3.2 Top 6 Intravenous Injection Immunoglobulin Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Intravenous Injection Immunoglobulin Sales, Revenue and Market Share by Regions
4.1.1 Global Intravenous Injection Immunoglobulin Sales and Market Share by Regions (2015-2020)
4.1.2 Global Intravenous Injection Immunoglobulin Revenue and Market Share by Regions (2015-2020)
4.2 North America Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
4.3 Europe Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
4.5 South America Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Intravenous Injection Immunoglobulin Sales, Revenue and Market Share by Country
5.1.1 North America Intravenous Injection Immunoglobulin Sales and Market Share by Country (2015-2020)
5.1.2 North America Intravenous Injection Immunoglobulin Revenue and Market Share by Country (2015-2020)
5.2 United States Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
5.3 Canada Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
5.4 Mexico Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Intravenous Injection Immunoglobulin Sales, Revenue and Market Share by Country
6.1.1 Europe Intravenous Injection Immunoglobulin Sales and Market Share by Country (2015-2020)
6.1.2 Europe Intravenous Injection Immunoglobulin Revenue and Market Share by Country (2015-2020)
6.2 Germany Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
6.3 UK Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
6.4 France Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
6.5 Russia Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
6.6 Italy Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Intravenous Injection Immunoglobulin Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Intravenous Injection Immunoglobulin Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Intravenous Injection Immunoglobulin Revenue and Market Share by Regions (2015-2020)
7.2 China Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
7.3 Japan Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
7.4 Korea Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
7.5 India Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
7.7 Australia Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Intravenous Injection Immunoglobulin Sales, Revenue and Market Share by Country
8.1.1 South America Intravenous Injection Immunoglobulin Sales and Market Share by Country (2015-2020)
8.1.2 South America Intravenous Injection Immunoglobulin Revenue and Market Share by Country (2015-2020)
8.2 Brazil Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
8.3 Argentina Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Intravenous Injection Immunoglobulin Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Intravenous Injection Immunoglobulin Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Intravenous Injection Immunoglobulin Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
9.3 Turkey Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
9.4 Egypt Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
9.5 South Africa Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Intravenous Injection Immunoglobulin Sales and Market Share by Type (2015-2020)
10.2 Global Intravenous Injection Immunoglobulin Revenue and Market Share by Type (2015-2020)
10.3 Global Intravenous Injection Immunoglobulin Price by Type (2015-2020)
11 Global Intravenous Injection Immunoglobulin Market Segment by Application
11.1 Global Intravenous Injection Immunoglobulin Sales Market Share by Application (2015-2020)
11.2 Global Intravenous Injection Immunoglobulin Revenue Market Share by Application (2015-2020)
11.3 Global Intravenous Injection Immunoglobulin Price by Application (2015-2020)
12 Market Forecast
12.1 Global Intravenous Injection Immunoglobulin Sales, Revenue and Growth Rate (2021-2025)
12.2 Intravenous Injection Immunoglobulin Market Forecast by Regions (2021-2025)
12.2.1 North America Intravenous Injection Immunoglobulin Market Forecast (2021-2025)
12.2.2 Europe Intravenous Injection Immunoglobulin Market Forecast (2021-2025)
12.2.3 Asia-Pacific Intravenous Injection Immunoglobulin Market Forecast (2021-2025)
12.2.4 South America Intravenous Injection Immunoglobulin Market Forecast (2021-2025)
12.2.5 Middle East & Africa Intravenous Injection Immunoglobulin Market Forecast (2021-2025)
12.3 Intravenous Injection Immunoglobulin Market Forecast by Type (2021-2025)
12.3.1 Global Intravenous Injection Immunoglobulin Sales Forecast by Type (2021-2025)
12.3.2 Global Intravenous Injection Immunoglobulin Market Share Forecast by Type (2021-2025)
12.4 Intravenous Injection Immunoglobulin Market Forecast by Application (2021-2025)
12.4.1 Global Intravenous Injection Immunoglobulin Sales Forecast by Application (2021-2025)
12.4.2 Global Intravenous Injection Immunoglobulin Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Intravenous Injection Immunoglobulin Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Intravenous Injection Immunoglobulin by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Intravenous Injection Immunoglobulin Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Intravenous Injection Immunoglobulin Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Boya-Bio Basic Information, Manufacturing Base and Competitors
Table 9. Boya-Bio Intravenous Injection Immunoglobulin Major Business
Table 10. Boya-Bio Intravenous Injection Immunoglobulin Total Revenue (USD Million) (2018-2019)
Table 11. Boya-Bio SWOT Analysis
Table 12. Boya-Bio Intravenous Injection Immunoglobulin Product and Services
Table 13. Boya-Bio Intravenous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. CTBB Basic Information, Manufacturing Base and Competitors
Table 15. CTBB Intravenous Injection Immunoglobulin Major Business
Table 16. CTBB Intravenous Injection Immunoglobulin Total Revenue (USD Million) (2018-2019)
Table 17. CTBB SWOT Analysis
Table 18. CTBB Intravenous Injection Immunoglobulin Product and Services
Table 19. CTBB Intravenous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Guangdong Shuagnlin Bio-pharmacy Basic Information, Manufacturing Base and Competitors
Table 21. Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Major Business
Table 22. Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Total Revenue (USD Million) (2018-2019)
Table 23. Guangdong Shuagnlin Bio-pharmacy SWOT Analysis
Table 24. Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Product and Services
Table 25. Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Beijing Tiantan Biological Products Basic Information, Manufacturing Base and Competitors
Table 27. Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Major Business
Table 28. Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Total Revenue (USD Million) (2018-2019)
Table 29. Beijing Tiantan Biological Products SWOT Analysis
Table 30. Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Product and Services
Table 31. Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table 33. Shanghai RAAS Intravenous Injection Immunoglobulin Major Business
Table 34. Shanghai RAAS Intravenous Injection Immunoglobulin Total Revenue (USD Million) (2018-2019)
Table 35. Shanghai RAAS SWOT Analysis
Table 36. Shanghai RAAS Intravenous Injection Immunoglobulin Product and Services
Table 37. Shanghai RAAS Intravenous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 39. Hualan Bio Intravenous Injection Immunoglobulin Major Business
Table 40. Hualan Bio Intravenous Injection Immunoglobulin Total Revenue (USD Million) (2018-2019)
Table 41. Hualan Bio SWOT Analysis
Table 42. Hualan Bio Intravenous Injection Immunoglobulin Product and Services
Table 43. Hualan Bio Intravenous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Sinopharm Basic Information, Manufacturing Base and Competitors
Table 45. Sinopharm Intravenous Injection Immunoglobulin Major Business
Table 46. Sinopharm Intravenous Injection Immunoglobulin Total Revenue (USD Million) (2018-2019)
Table 47. Sinopharm SWOT Analysis
Table 48. Sinopharm Intravenous Injection Immunoglobulin Product and Services
Table 49. Sinopharm Intravenous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Weiguang Biological Basic Information, Manufacturing Base and Competitors
Table 51. Weiguang Biological Intravenous Injection Immunoglobulin Major Business
Table 52. Weiguang Biological Intravenous Injection Immunoglobulin Total Revenue (USD Million) (2018-2019)
Table 53. Weiguang Biological SWOT Analysis
Table 54. Weiguang Biological Intravenous Injection Immunoglobulin Product and Services
Table 55. Weiguang Biological Intravenous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Nanyue Biopharming Basic Information, Manufacturing Base and Competitors
Table 57. Nanyue Biopharming Intravenous Injection Immunoglobulin Major Business
Table 58. Nanyue Biopharming Intravenous Injection Immunoglobulin Total Revenue (USD Million) (2018-2019)
Table 59. Nanyue Biopharming SWOT Analysis
Table 60. Nanyue Biopharming Intravenous Injection Immunoglobulin Product and Services
Table 61. Nanyue Biopharming Intravenous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Global Intravenous Injection Immunoglobulin Sales by Manufacturer (2018-2019) (L)
Table 63. Global Intravenous Injection Immunoglobulin Revenue by Manufacturer (2018-2019) (USD Million)
Table 64. Global Intravenous Injection Immunoglobulin Sales by Regions (2015-2020) (L)
Table 65. Global Intravenous Injection Immunoglobulin Sales Market Share by Regions (2015-2020)
Table 66. Global Intravenous Injection Immunoglobulin Revenue by Regions (2015-2020) (USD Million)
Table 67. North America Intravenous Injection Immunoglobulin Sales by Countries (2015-2020) (L)
Table 68. North America Intravenous Injection Immunoglobulin Sales Market Share by Countries (2015-2020)
Table 69. North America Intravenous Injection Immunoglobulin Revenue by Countries (2015-2020) (USD Million)
Table 70. North America Intravenous Injection Immunoglobulin Revenue Market Share by Countries (2015-2020)
Table 71. Europe Intravenous Injection Immunoglobulin Sales by Countries (2015-2020) (L)
Table 72. Europe Intravenous Injection Immunoglobulin Sales Market Share by Countries (2015-2020)
Table 73. Europe Intravenous Injection Immunoglobulin Revenue by Countries (2015-2020) (USD Million)
Table 74. Asia-Pacific Intravenous Injection Immunoglobulin Sales by Regions (2015-2020) (L)
Table 75. Asia-Pacific Intravenous Injection Immunoglobulin Sales Market Share by Regions (2015-2020)
Table 76. Asia-Pacific Intravenous Injection Immunoglobulin Revenue by Regions (2015-2020) (USD Million)
Table 77. South America Intravenous Injection Immunoglobulin Sales by Countries (2015-2020) (L)
Table 78. South America Intravenous Injection Immunoglobulin Sales Market Share by Countries (2015-2020)
Table 79. South America Intravenous Injection Immunoglobulin Revenue by Countries (2015-2020) (USD Million)
Table 80. South America Intravenous Injection Immunoglobulin Revenue Market Share by Countries (2015-2020)
Table 81. Middle East & Africa Intravenous Injection Immunoglobulin Sales by Countries (2015-2020) (L)
Table 82. Middle East & Africa Intravenous Injection Immunoglobulin Sales Market Share by Countries (2015-2020)
Table 83. Middle East & Africa Intravenous Injection Immunoglobulin Revenue by Countries (2015-2020) (USD Million)
Table 84. Middle East & Africa Intravenous Injection Immunoglobulin Revenue Market Share by Countries (2015-2020)
Table 85. Global Intravenous Injection Immunoglobulin Sales by Type (2015-2020) (L)
Table 86. Global Intravenous Injection Immunoglobulin Sales Share by Type (2015-2020)
Table 87. Global Intravenous Injection Immunoglobulin Revenue by Type (2015-2020) (USD Million)
Table 88. Global Intravenous Injection Immunoglobulin Revenue Share by Type (2015-2020)
Table 89. Global Intravenous Injection Immunoglobulin Sales by Application (2015-2020) (L)
Table 90. Global Intravenous Injection Immunoglobulin Sales Share by Application (2015-2020)
Table 91. Global Intravenous Injection Immunoglobulin Sales Forecast by Regions (2021-2025) (L)
Table 92. Global Intravenous Injection Immunoglobulin Market Share Forecast by Regions (2021-2025)
Table 93. Global Intravenous Injection Immunoglobulin Sales Forecast by Type (2021-2025) (L)
Table 94. Global Intravenous Injection Immunoglobulin Market Share Forecast by Type (2021-2025)
Table 95. Global Intravenous Injection Immunoglobulin Sales Forecast by Application (2021-2025)
Table 96. Global Intravenous Injection Immunoglobulin Market Share Forecast by Application (2021-2025)
Table 97. Direct Channel Pros & Cons
Table 98. Indirect Channel Pros & Cons
Table 99. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Intravenous Injection Immunoglobulin Picture
Figure 2. Global Sales Market Share of Intravenous Injection Immunoglobulin by Type in 2019
Figure 3. 1g/20ml Picture
Figure 4. 1.25g/25ml Picture
Figure 5. 2.5g/50ml Picture
Figure 6. 5g/100ml Picture
Figure 7. 10g/200ml Picture
Figure 8. Intravenous Injection Immunoglobulin Sales Market Share by Application in 2018
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Others Picture
Figure 12. Global Intravenous Injection Immunoglobulin Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Intravenous Injection Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Intravenous Injection Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Intravenous Injection Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Intravenous Injection Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Intravenous Injection Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Intravenous Injection Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Intravenous Injection Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Intravenous Injection Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Intravenous Injection Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Intravenous Injection Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Intravenous Injection Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Intravenous Injection Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Intravenous Injection Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Intravenous Injection Immunoglobulin Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Intravenous Injection Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Intravenous Injection Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Intravenous Injection Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Intravenous Injection Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Intravenous Injection Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Intravenous Injection Immunoglobulin Sales Market Share by Manufacturer in 2019
Figure 33. Global Intravenous Injection Immunoglobulin Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Intravenous Injection Immunoglobulin Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Intravenous Injection Immunoglobulin Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020) (L)
Figure 38. Global Intravenous Injection Immunoglobulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Intravenous Injection Immunoglobulin Revenue Market Share by Regions (2015-2020)
Figure 40. Global Intravenous Injection Immunoglobulin Revenue Market Share by Regions in 2018
Figure 41. North America Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
Figure 42. Europe Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
Figure 44. South America Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020)
Figure 46. North America Intravenous Injection Immunoglobulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Intravenous Injection Immunoglobulin Sales Market Share by Countries (2015-2020)
Figure 48. North America Intravenous Injection Immunoglobulin Sales Market Share by Countries in 2018
Figure 49. North America Intravenous Injection Immunoglobulin Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Intravenous Injection Immunoglobulin Revenue Market Share by Countries in 2018
Figure 51. United States Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020) (L)
Figure 52. Canada Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020) (L)
Figure 53. Mexico Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020) (L)
Figure 54. Europe Intravenous Injection Immunoglobulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Intravenous Injection Immunoglobulin Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Intravenous Injection Immunoglobulin Revenue Market Share by Countries in 2019
Figure 57. Germany Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020) (L)
Figure 58. UK Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020) (L)
Figure 59. France Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020) (L)
Figure 60. Russia Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020) (L)
Figure 61. Italy Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020) (L)
Figure 62. Asia-Pacific Intravenous Injection Immunoglobulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Intravenous Injection Immunoglobulin Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Intravenous Injection Immunoglobulin Revenue Market Share by Regions 2019
Figure 65. China Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020) (L)
Figure 66. Japan Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020) (L)
Figure 67. Korea Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020) (L)
Figure 68. India Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020) (L)
Figure 69. Southeast Asia Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020) (L)
Figure 70. South America Intravenous Injection Immunoglobulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Intravenous Injection Immunoglobulin Sales Market Share by Countries in 2019
Figure 72. South America Intravenous Injection Immunoglobulin Revenue Market Share by Countries in 2019
Figure 73. Brazil Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020) (L)
Figure 74. Argentina Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020) (L)
Figure 75. Middle East and Africa Intravenous Injection Immunoglobulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Intravenous Injection Immunoglobulin Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Intravenous Injection Immunoglobulin Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Intravenous Injection Immunoglobulin Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020) (L)
Figure 80. Egypt Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020) (L)
Figure 81. Turkey Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020) (L)
Figure 82. South Africa Intravenous Injection Immunoglobulin Sales and Growth Rate (2015-2020) (L)
Figure 83. Global Intravenous Injection Immunoglobulin Sales and Growth Rate (2021-2025) (L)
Figure 84. Global Intravenous Injection Immunoglobulin Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Intravenous Injection Immunoglobulin Market Forecast (2021-2025) (L)
Figure 86. Europe Sales Intravenous Injection Immunoglobulin Market Forecast (2021-2025) (L)
Figure 87. Asia-Pacific Sales Intravenous Injection Immunoglobulin Market Forecast (2021-2025) (L)
Figure 88. South America Sales Intravenous Injection Immunoglobulin Market Forecast (2021-2025) (L)
Figure 89. Middle East & Africa Sales Intravenous Injection Immunoglobulin Market Forecast (2021-2025) (L)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
静脈内注射用ヒト免疫グロブリン（PH4）の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Human Immumoglobulin (PH4) for Intravenous Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market pla…- 静脈内（IV）溶液の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Intravenous (IV) Solution market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.2% in the forecast period of 2020 to 2025 and will expected to reach USD 9330.3 million by 2025, from USD 7922.8 million in 2019. The Intravenou…
- 自己注射デリバリーシステムの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Self-Injection Delivery Systems market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Self-Injectio…
- 馬狂犬病免疫グロブリン（ERIG）の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Equine Rabies Immunoglobulin (ERIG) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…
- ヒト正常免疫グロブリンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Human Normal Immunoglobulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…